TotalMarketCap

Corcept Therapeutics

CORTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.860 B

$71.82 -9.35%

Close of 6 Nov 2026

As of 6 Nov 2026, Corcept Therapeutics (CORT) has a market capitalization of $7.86B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$761.4M

#1667 by revenue

Earnings

$99.7M

#1305 by earnings

Shares outstanding

109,443,109

Latest filing cover page

P/E ratio

78.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #36Protagonist TherapeuticsPTGX$8.76B
  2. #37Arrowhead PharmaceuticalsARWR$8.11B
  3. #38Corcept TherapeuticsCORT$7.86B
  4. #39CytokineticsCYTK$7.74B
  5. #40AlkermesALKS$7.50B

What if Corcept Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$258,005.04

Per share 3,593× higher

Bitcoin $1.53T

$13,960.20

Per share 194× higher

Apple $5.02T

$45,830.05

Per share 638× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Corcept Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.